Aclarion 8181 Arista Place, Suite 100 Broomfield, CO 80021 [email protected] 833-ASK-ACON (833-275-2266)

Jan 15, 2025 · Aclarion is a healthcare technology company focused on advancing the care of patients by combining the imaging capabilities of magnetic resonance spectroscopy (MRS) with a proprietary, augmented-intelligence algorithm to noninvasively deliver SaaS solutions that help physicians personalize treatment plans to support improved clinical outcomes ...

Mr. Ness became the Chief Executive Officer of Aclarion in September 2021. Mr. Ness has over 25 years of medical device and healthcare technology experience and has held various executive and senior leadership positions, including recently as CCO of Cleerly, Inc.

Aclarion is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (“MRS”), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments.

Jan 24, 2025 · Aclarion is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments.

Jan 17, 2024 · With this product release Nociscan can now be performed on MRI machines beyond those manufactured by Siemens. “This important technical milestone expands Nociscan access to healthcare providers and patients throughout the world in a very significant way,” stated Brent Ness, CEO of Aclarion.

Aclarion is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (“MRS”), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments.

Sep 10, 2024 · Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey

Globally, 266 million people suffer from degenerative spine disease and low back pain. Aclarion’s Nociscan solution is the first evidence-supported SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine.

As a disruptive healthcare technology company focused on chronic low back pain, Aclarion is at the forefront of developing noninvasive tools to help physicians identify the source of pain in spinal discs, potentially revolutionizing the standard of care for this widespread and debilitating condition.